Glucophage

Chronic Pancreatitis

Changhai HospitalUNKNOWNN/AActive

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 95/ 100

Competitive context

8 Active assets in the Chronic Pancreatitis cohort.

Asset / Sponsor	Phase	Rating
Marcaine Johns Hopkins University	Phase 3	BB
Pancrelipase Changhai Hospital	Phase 4	BB
Kenacort Centre hospitalier de l'Université de Montréal (CHUM)	Phase 3	BB
Pregabalin Asian Institute of Gastroenterology, India	Phase 2/3	B
Pioglitazone University of Michigan	Phase 2	B

View all 21 →

Same molecule, other indications

Glucophage is also rated in:

polycystic ovary syndromeActive

BBB

Indicative · Phase 4

75 / 100

obesity disorderDormant

BB

Indicative · Phase 4

67 / 100

exocrine pancreatic insufficiencyActive

D

Indicative · N/A

30 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.